Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic
-
By
-
Lizete Braivo
-
Viktorija Truškova
-
Aļona Lavrenova
-
Anda Ķīvīte-Urtāne
-
Jana Pavāre
-
Iveta Dzīvīte-Krišāne
-
May 22, 2026
-
Clinical Scorecard: Rising Rates and Severity of Pediatric Type 1 Diabetes Onset in Latvia Amid the COVID-19 Pandemic
At a Glance
| Category | Detail |
| Condition | |
| Key Mechanisms | Influence of SARS-CoV-2 virus on metabolism and immune response, leading to increased incidence and severity of T1D, as evidenced by study findings. |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- Monitor patients with a history of COVID-19 for more severe manifestations of T1D.
- Consider specific therapies or interventions based on severity.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Include specific treatment protocols for managing T1D in children with a history of COVID-19.
Clinical Best Practices
Related Resources & Content